News
SeaStar Medical Highlights Publication Of Clinical Trial Results Demonstrating Its SCD 'Significantly Lowered Mortality Rates Among Critically Ill ICU COVID-19 Patients By Safely And Effectively Stopping Inflammation Causing Cytokine Storms'
7 Jun 22
Biotech, General
SeaStar Medical To Become Publicly Listed On Nasdaq via Business Combination with LMF Acquisition Opportunities
22 Apr 22
M&A